Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
Clinical trial NCT00083694 · COMPLETED
Trial details
- NCT number
- NCT00083694
- Sponsor
- University of Arkansas
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.